"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778

"In vivo hemin conditioning targets the vascular and immunologic compartments and restrains prostate tumor development" (2017) Jaworski, F.M.;Gentilini, L.D.;Gueron, G. (...)Vazquez, E.S. Clinical Cancer Research. 23(17):5135-5148

"RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors" (2016) Wu, Y.;Tedesco, L.;Lucia, K. (...)Stalla, G.K. Oncotarget. 7(36):57878-57893

"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63

"Electrochemotherapy in non-satisfactory responding tumors in vet patients: Combined administration of bleomycin, systemic and local" (2016) Maglietti, F.;Tellado, M.;Olaiz, N. (...)Jarm T. 1st World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food and Environmental Technologies, WC 2015. 53:445-448

"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54

"RSUME inhibits VHL and regulates its tumor suppressor function" (2015) Gerez, J.;Tedesco, L.;Bonfiglio, J.J. (...)Arzt, E. Oncogene. 34(37):4855-4866

"Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference" (2014) Croci, D.O.; Rabinovich, G.A. OncoImmunology. 3(6)

"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290

"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262

"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)

"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96

"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558

"Aquaporins: Another piece in the osmotic puzzle" (2012) Alleva, K.; Chara, O.; Amodeo, G. FEBS Letters. 586(19):2991-2999

"Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer" (2011) Ferrando, M.;Gueron, G.;Elguero, B. (...)Vazquez, E. Angiogenesis. 14(4):467-479

"Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from laminaria saccharina brown seaweed" (2011) Croci, D.O.;Cumashi, A.;Ushakova, N.A. (...)Nifantiev, N.E. PLoS ONE. 6(2)

"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774

"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40

"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft" (2007) Gazzaniga, S.;Bravo, A.I.;Guglielmotti, A. (...)Wainstok, R. Journal of Investigative Dermatology. 127(8):2031-2041

"Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: Detection of a non-endothelial function of VEGF in pituitary tumours" (2006) Onofri, C.;Theodoropoulou, M.;Losa, M. (...)Renner, U. Journal of Endocrinology. 191(1):249-261